Collier Lane, Grimshaw Sarah L, Stolper Julian, Passmore Elyse, Ball Gareth, Elliott David A, Conyers Rachel
Cancer Therapies, Murdoch Children's Research Institute, Flemington Road, Parkville, Victoria, 3052, Australia.
Department of Paediatrics, University of Melbourne, Flemington Road, Parkville, Victoria, 3052, Australia.
NPJ Digit Med. 2025 Jul 31;8(1):488. doi: 10.1038/s41746-025-01842-5.
This review summarizes the current literature on the use of wearable devices for collecting physiological data in pediatric and young adult (0-25 years) oncology. Searches were conducted in MEDLINE, PubMed and Embase, focusing on pediatric and young adult patients with a cancer diagnosis, and utilizing a wearable device during and/or after treatment. Of the 77 articles that met the inclusion criteria, 61 studies primarily used wearable devices as a tool to monitor physiological changes in an interventional or observational setting. Only 16 studies integrated wearable devices as an active component of the intervention. The most reported wearable device brands were ActiGraph (19, 24.7%), FitBit (14, 18.2%), Ambulatory Monitoring Inc. (11, 14.3%) and Philips Respironics (10, 13%). This scoping review offers valuable insights into the current use of wearable devices in pediatric and young adult (0-25 years) oncology but also reveals notable gaps in the literature.
本综述总结了目前关于在儿科和青年（0至25岁）肿瘤学中使用可穿戴设备收集生理数据的文献。检索了MEDLINE、PubMed和Embase数据库，重点关注患有癌症诊断的儿科和青年患者，以及在治疗期间和/或治疗后使用可穿戴设备的情况。在符合纳入标准的77篇文章中，61项研究主要将可穿戴设备用作在干预或观察环境中监测生理变化的工具。只有16项研究将可穿戴设备作为干预的一个积极组成部分。报告最多的可穿戴设备品牌是ActiGraph（19个，24.7%）、FitBit（14个，18.2%）、动态监测公司（11个，14.3%）和飞利浦伟康（10个，13%）。这项范围综述为目前可穿戴设备在儿科和青年（0至25岁）肿瘤学中的应用提供了有价值的见解，但也揭示了文献中明显的空白。
